Tonix Pharmaceuticals Hol... (TNXP)
Tonix Pharmaceuticals Statistics
Share Statistics
Tonix Pharmaceuticals has 7.32M shares outstanding. The number of shares has increased by 2964.8% in one year.
| 7.32M |
| 2964.8% |
| 14.77% |
| 0% |
| n/a |
| 3,970 |
| 0.24% |
Short Selling Information
The latest short interest is 908.35K, so 12.4% of the outstanding shares have been sold short.
| 908.35K |
| 12.4% |
| 12.4% |
| 1.43 |
Valuation Ratios
The PE ratio is -0.57 and the forward PE ratio is -6.39. Tonix Pharmaceuticals's PEG ratio is 0.01.
| -0.57 |
| -6.39 |
| 7.4 |
| 0.4 |
| 0.53 |
| -1.22 |
| 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tonix Pharmaceuticals.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 6.5, with a Debt / Equity ratio of 0.06.
| 6.5 |
| 6.04 |
| 0.06 |
| -0.11 |
| -0.13 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $124,617.28 |
| $-1,605,382.72 |
| 81 |
| 0.06 |
| 0.92 |
Taxes
| -1.17M |
| 0.9% |
Stock Price Statistics
The stock price has increased by -89% in the last 52 weeks. The beta is 2.1, so Tonix Pharmaceuticals's price volatility has been higher than the market average.
| 2.1 |
| -89% |
| 22.97 |
| 21.19 |
| 67.34 |
| 1,650,757 |
Income Statement
In the last 12 months, Tonix Pharmaceuticals had revenue of 10.09M and earned -130.04M in profits. Earnings per share was -3504.
| 10.09M |
| 2.33M |
| -77.74M |
| -130.04M |
| -74.94M |
| -75.7M |
| -3504 |
Balance Sheet
The company has 98.78M in cash and 8.12M in debt, giving a net cash position of 90.66M.
| 98.78M |
| 8.12M |
| 90.66M |
| -730.69M |
| 192.87M |
| 137.43M |
Cash Flow
In the last 12 months, operating cash flow was -60.92M and capital expenditures -120K, giving a free cash flow of -61.05M.
| -60.92M |
| -120K |
| -61.05M |
| -26.97 |
Margins
Gross margin is 23.07%, with operating and profit margins of -770.2% and -1288.25%.
| 23.07% |
| -770.2% |
| -1288.25% |
| -1288.25% |
| -742.39% |
| -770.2% |
| -604.77% |
Dividends & Yields
TNXP does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for TNXP is $585, which is 1427.4% higher than the current price. The consensus rating is "Strong Buy".
| $585 |
| 1427.4% |
| Strong Buy |
| 2 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Feb 5, 2025. It was a backward split with a ratio of 1:100.
| Feb 5, 2025 |
| backward |
| 1:100 |
Scores
| 9.04 |
| 5 |